Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMTPH.L Share News (MTPH)

  • There is currently no data for MTPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS & LOSERS SUMMARY: ARM Hit By iPhone Production Cut Report

Wed, 06th Jan 2016 10:18

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Wednesday.
----------
FTSE 100 - WINNERS
----------
Royal Mail, up 1.9%. Barclays upgraded the postal service operator to Overweight from Equal Weight and hiked its price target to 575 pence from 440p. Royal Mail shares were trading at 444.80p. The bank expects a new pay deal to be negotiated in the first quarter of 2016 and for the company to resolve the issues around its defined benefit pension scheme by the second half. Barclays also said it was confident the cost-cutting measures Royal Mail is taking will keep costs broadly flat, allowing any rise in revenue to feed through to the bottom line. It is the second vote of confidence in Royal Mail shares in as many days. Cantor Fitzgerald upgraded the postal operator to Buy from Hold on Tuesday.

BAE Systems, up 1.9%. RBC Capital Markets upgraded its rating on BAE Systems to Top Pick from Outperform, hiking its target price to 630 pence from 570p. BAE was trading at 501p.
----------
FTSE 100 - LOSERS
----------
ARM Holdings, down 3.0%. The company, which designs semiconductors that are used in Apple's iPhones, was hit after a report in Japan's Nikkei Asian Review said Apple is expected to reduce the output of iPhone 6s and 6s Plus models by around 30% in the January-March quarter compared with its original plans. The report said inventories of the two models, which launched last September, have piled up at retailers in markets ranging from China and Japan to Europe and the US amid lackluster sales. Customers saw little improvement in performance over the previous generation, while dollar appreciation led to sharp price hikes in emerging markets.
----------
FTSE 250 - WINNERS
----------
Card Factory, up 0.9%. Card Factory has appointed Karen Hubbard as its chief executive designate, with effect from February 22. The greeting cards and gifts retailer hired Hubbard from discount retailer B&M European Value Retail, where she has been chief operating officer since 2014. Prior to this, she worked in a number of roles at Asda, the Wal-Mart Stores-owned UK supermarket chain, including heading its property, format development and multi-channel business. She will take over from Card Factory's current chief executive, Richard Hayes, in mid-April. The company also said Christmas trading had been in line with its expectations.
----------
FTSE 250 - LOSERS
----------
Home Retail Group, down 4.5%. The owner of Argos and Homebase gave back some gains made on Tuesday, when it closed up 34% following the news FTSE 100-listed grocer J Sainsbury had made an unsolicited bid for the company in November, which Home Retail rejected. Home Retail has been the subject of speculation about a potential takeover offer ever since its shares slumped in October following a profit warning, hit by investments in restructuring the business and slower-than-expected trading. Sainsbury's shares were down 0.9%.
----------
MAIN MARKET AND AIM - WINNERS
----------
Sula Iron & Gold, up 22%. The miner said its chief executive said the assay results from the recent drilling campaign on the Ferensola gold project in Sierra Leone exceeded his expectations and leads him to believe there is a major high-grade deposit. "I am excited by the results of the second batch of drill core samples from the extended scout drilling programme at our Ferensola Gold Project, together with the samples of 'goldstones' as they exceed my best-case expectations," said Nick Warrel.

Corero Network Security, up 15%. The security systems developer said it has secured a USD700,000 order for its SmartWall Threat Defense System product from an undisclosed European internet service provider. Under the order Corero will provide protection against distributed denial of service attacks, a form of hack that makes on online service unavailable by overwhelming it with traffic from multiple sources, as a service for one of the ISP's "high profile" customers.

Midatech Pharma, up 12%. The specialty pharmaceutical company said 2015 revenue will be "slightly ahead of expectations" following its recent acquisitions of Dara BioSciences and Zuplenz, and it also forecast revenue growth at the higher end of market forecasts for 2016. "Following the acquisition of DARA BioSciences and Zuplenz, and further licensing and supply agreements, 2015 has shown significant growth for Midatech, achieving the strategic objectives set out at the time of the IPO and accelerating the company towards sustainable profitability," said Chief Executive Officer Jim Phillips in a statement.
----------
By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
11 Apr 2016 12:20

Midatech Pharma Announces Launch Of Zuplenz In US

Read more
6 Jan 2016 07:57

Midatech Pharma 2015 Revenue To Come In Ahead Of Expectations

Read more
4 Jan 2016 14:18

Midatech particle technology to be used in vaccines

(ShareCast News) - Midatech Pharma's proprietary technology received a boost on Monday, with the news it had signed a licensing agreement with a private British biotechnology company. The AIM-listed pharmaceutical company - focused on products in oncology and other therapeutic areas - reported it ha

Read more
4 Jan 2016 07:35

Midatech Pharma Signs Licensing Deal With Emergex Vaccines

Read more
18 Dec 2015 09:53

Midatech Pharma Agrees To Buy Zuplenz From Galena Biopharma

Read more
18 Dec 2015 09:39

BROKER RATINGS SUMMARY: UBS Initiates Restaurant Group At Buy

Read more
14 Dec 2015 08:28

Midatech Pharma Appoints Centurion Pharma For Q-Octreotide In Turkey

Read more
4 Dec 2015 09:33

BROKER RATINGS SUMMARY: Barclays Downgrades Whitbread To Equal Weight

Read more
19 Nov 2015 10:00

Midatech Pharma Files Supplemental Disclosure In Relation To DARA Buy

Read more
15 Sep 2015 08:42

BROKER RATINGS SUMMARY: UBS Initiates Legal & General With Sell

Read more
14 Sep 2015 08:08

Midatech Pharma Loss Widens On Acquisition Costs, Investment

Read more
13 Aug 2015 07:00

Midatech Signs Deal With Eye Disesases Company Ophthotech

Read more
23 Jul 2015 08:04

Midatech Pharma Begins Phase IIa Study For MSL-001

Read more
23 Jun 2015 14:57

DIRECTOR DEALINGS: Midatech Pharma Finance Director Buys 500 Shares

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.